Recommendations from medical authorities and regular monitoring by healthcare providers support effective treatment and management of any issues that arise
By mimicking the GLP-1 hormone, slowing stomach emptying, and reducing glucagon release, it provides multiple benefits for people with type 2 diabetes and those struggling with weight management
The medicine remains under investigation
It works by increasing the amount of insulin your body releases after you eat
Unlike other approved GLP-1 medications, Wegovy and Zepbound, which also target the gut hormone GLP-1, retatrutide targets three receptors known to regulate appetiteGLP-1, glucagon and glucose-dependent insulinotropic polypeptide (GIP)
Eli Lillys Lilly Cares program covers Mounjaro and Zepbound for patients at or below 300% of the federal poverty level